| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.4 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |